The state of Kansas currently has 13 active clinical trials seeking participants for Pulmonary Fibrosis research studies. These trials are conducted in various cities, including Wichita, Kansas City, Overland Park and Topeka.
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
Recruiting
This is a randomized, double-blinded, placebo-controlled multicenter study to evaluate the safety and efficacy of DWN12088 in patients with Idiopathic Pulmonary Fibrosis.
Gender:
All
Ages:
40 years and above
Trial Updated:
04/16/2024
Locations: University of Kansas Medical Center Research Institute, Inc, Kansas City, Kansas
Conditions: Idiopathic Pulmonary Fibrosis